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Nanomedicine, the application of nanotechnology to thediagnostics and treatment of diseases, is seeing enormous
development. This is being fueled by the advances in laser-
induced techniques as well as by the synthesis of sophisticated
nanoparticles, which are functional and biologically robust.1 For
example, plasmonic nanoparticles are increasingly employed as
agents in cancer theranostics because of their favorable optoelec-
tronic properties, provided by the tunable near-infrared absorp-
tion band, and their ability to eﬃciently convert light to heat.
Several research groups reported the use of engineered gold
nanoparticles as biomarkers to detect cells in vitro and In Vivo2
and as agents to selectively destroy tumors using the method of
destructive hyperthermia.3 Currently, functional nanoparticles
are being tested in clinical trials to explore their potential for use
in human therapy.
Apart from its potential for destroying cancer cells, nanopar-
ticle-laser-induced heat delivery has been successfully employed
for releasing small molecules such as drugs4 and labeled DNA,5
and for enhancing the toxicity of conventional chemother-
apeutics.6 Although most work on laser-induced nanoparticle
cell treatment report a minimal energy threshold required for
achieving cell mortality, very little eﬀort has beenmade to explore
the window of opportunity of using laser treatment as a direct,
mild tool for manipulating damage and repair of biological cells.
A major reason of the damage caused in cells during laser
treatment is attributed to thermal eﬀects.7 For example, in
single-particle studies it was found that irradiation of nanopar-
ticles using a continuous wave laser locally melts a lipid
membrane,8 while illumination using a high-power pulsed laser
showed disintegration of the cell membrane.3g However, the
explanation for the cell damage response induced by nanoparti-
cles is nontrivial due to its dependence on nanoscale physico-
chemical mechanisms around a single nanoparticle. Expanding
the opportunities for applications of laser treatment in biology,
Volk and co-workers showed that low laser irradiation of cancer
cells containing endosomal gold nanoparticles could generate
free radicals leading to controlled endosome rupture and nano-
particle escape into the cytosol, without aﬀecting the cell’s
viability.9
Here, we explore a window of laser-induced nanoparticle
treatment, occurring at power densities of 10-24 W/cm2, i.e.
below the threshold of most destructive studies, to achieve
nondestructive mild forms of laser-induced treatment. In com-
parison to other studies involving low laser power (i.e., drug
delivery), we use targeted nanoparticles to gain control over the
permeability of the cellular membrane as well as the expression
of genes.
Our investigation focuses on an important type of noncancer-
ous cells, the endothelial. Endothelial cells are a specialized type
of cell, which forms the inner layer of blood vessels and plays a
pivotal role in the processes of new blood vessel formation
(angiogenesis), inﬂammation blood pressure, and coagulation.
We employed particles, which were functionalized either with
peptides that target speciﬁc cell surface receptors or without
peptides to allow them to be endocytosed. To assess the
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ABSTRACT: Laser-induced techniques that employ the sur-
face plasmon resonances of nanoparticles have recently been
introduced as an eﬀective therapeutic tool for destroying tumor
cells. Here, we adopt a low-intensity laser-induced technique to
manipulate the damage and repair of a vital category of
noncancerous cells, human endothelial cells. Endothelial cells
construct the interior of blood vessels and play a pivotal role in
angiogenesis. The degree of damage and repair of the cells is
shown to be inﬂuenced by laser illumination in the presence of
gold nanoparticles of diﬀerent morphologies, which either
target the cellular membrane or are endocytosed. A pronounced inﬂuence of the plasmonic nanoparticle laser treatment on the
expression of critical angiogenic genes is shown. Our results show that plasmon-mediated mild laser treatment, combined with
speciﬁc targeting of cellular membranes, enables new routes for controlling cell permeability and gene regulation in endothelial cells.
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inﬂuence of nanoparticle morphology in the laser-induced treat-
ment, we used three diﬀerent types of nanoparticles: gold
nanorods (NR), gold hollow spheres (HG), and core/shell
silica/gold spheres (CS) (see Figure 1). The nanoparticle
morphologies were optimized to yield plasmon absorption bands
in the near-IR region where the light can penetrate both blood
and soft tissues (Figure 2).10 The particles were coated with
monocarboxy(1-mercaptoundec-11-yl) hexa(ethylene glycol)
(OEG), in order to introduce a terminal carboxylic group that
has been shown to react with amine-terminated peptides, using
standard coupling chemistry.11 Targeted attachment of the
particles to the cellular membrane of human umbilical vein
endothelial cells (HUVECs) was achieved by functionalizing
them with the KPQPRPLS peptide (pep). We have recently
demonstrated that nanoparticles functionalized with this peptide
preferentially bind to the vascular endothelial growth factor
receptors (VEGFR-1).12
The nanoparticles were characterized using several techniques
such as transmission electron microscopy, dynamic light scatter-
ing, zeta potential measurements, and visible spectroscopy (see
Figures 1 and 2 and Supporting Information).
A series of experiments were performed where functionalized
(pep-OEG-HG, pep-OEG-NR, pep-OEG-CS) and nonfunctio-
nalized (OEG-HG, OEG-NR, OEG-CS) particles were incu-
bated with the endothelial cells and subsequently exposed to a
range of laser power densities. Consistent with our previous
work,12 the functionalized particles were mostly bound to the
cellular membrane while the nonfunctionalized were internalized
and conﬁned in endosomes (see Supporting Information for
TEM images of cross-sectioned samples). As illumination source
for the laser-induced treatment, we used light from a super-
continuum ﬁber source (Fianium, 4 ps pulse length, 40 MHz
repetition rate), which was ﬁltered to a spectral range of 680-
720 nm using a bandpass ﬁlter. The laser power was varied
between 0.75 and 5 mW yielding optical intensities in the cell
culture between 5 and 32W/cm2 over a spot of 200 μmdiameter.
A homogeneous, top-hat illumination proﬁle was achieved by
direct imaging of the output from a multimode ﬁber onto the cell
culture. The exposure times were ﬁxed to a value of 10 min for all
experiments. Following laser irradiation, cells were incubated for
either 1 or 24 h before staining the samples.
Figure 3 shows phase contrast images of cells incubated with
peptide-functionalized particles before and 1 h after illumination
at a laser intensity of 24 W/cm2. The cells incubated with pep-
OEG NPs show clear changes in morphology, while this is not
observed in cells incubated in the absence of nanoparticles
(control sample in Figure 3). Before treatment, the HUVECs
form a continuous layer displaying the typical cobblestone
pattern. After treatment, this pattern is strongly disrupted and
the cells show a detached morphology. A fraction of the cells also
exhibits a pronounced shape change and shrinkage (see insets of
Figure 3b). The eﬀects of laser-induced treatment were further
investigated by staining of the cells with Trypan Blue. Trypan
Blue is a dye which is excluded from live cells but passes into the
cytoplasm of cells exhibiting increased cell membrane perme-
ability. Presence of the dye inside cells is therefore an indicator
for cellular membrane rupture. As shown in Figure 3c, the
number of cells with ruptured membrane is larger in the case
of cells incubated with nanoparticles than in the control experi-
ment. Between diﬀerent types of nanoparticles, the hollow-gold
and nanorod samples show a larger membrane rupture eﬀect
than the core-shell sample.
To better understand these results and to monitor the
experimental conditions related to cell damage, we expanded
our study, treating several cell-nanoparticle samples with
diﬀerent laser power densities ranging from 5 to 32 W/cm2.
Figure 4 shows graphs of the six diﬀerent cell samples containing
functionalized or nonfunctionalized particles and treated with
various laser intensities. The damage of the cellular membrane
for the diﬀerent samples was monitored 1 and 24 h after laser
treatment. For all samples, an increase of the intensity resulted in
an increase in the percentage of the damaged cells. In the absence
of nanoparticles, a signiﬁcant increase in the number of damaged
cells appeared only after exposure at the highest laser intensity
used (32 W/cm2, see Supporting Information). These observa-
tions highlight, ﬁrst, the resistance of endothelial cells in tem-
perature variations in comparison to other types of cells (such as
tumors)13 and, second, the increase of ruptured cellular mem-
branes when nanoparticles are associated with the cells during
the laser treatment.
Figure 1. TEM images of nanoparticles used in the laser treatment
experiments: hollow gold (HG), gold nanorods (NR), and silica/gold
core-shell (CS). Scale bars represent 100 nm.
Figure 2. Optical extinction spectra of nanoparticles used in hyperther-
mia experiments. Nanoparticle shape and size are optimized for NIR
illumination with the laser excitation band at 700 ( 20 nm (red area).
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Pronounced diﬀerences in the damage of the cells are ob-
served in Figure 4 between samples containing diﬀerent kinds of
particles. For all the experiments, the greatest number of
ruptured cellular membranes (larger number of dyed cells) was
always observed for samples containing nanorods and hollow
gold particles, conﬁrming that these types of particles had a
dominant role on the cell damage.
The most striking observation in Figure 4 is that for the pep-
OEG-NPs samples, a large fraction of the cells showed a
recovery 24 h after the laser treatment, as indicated by the area
II (blue). The recovery is indicated by the absence of Trypan
Blue from the cytoplasm, which translates to the cells having an
intact cellular membrane. The repair of the cellular membrane
reaches over 40% for pep-OEG-HG and pep-OEG-NR and
around 30% in the case of pep-OEG-CS. Such cell recovery is
not (or only mildly) observed for the cells incubated with OEG-
NPs (Figure 4d-f). The reasons for these large diﬀerences in
cell damage between samples containing functional and non-
functional particles can be attributed to the way that the
particles interact with each cell.12 The functional particles
(pep-OEG NPs) interact speciﬁcally with the VEGFR-1 recep-
tors and they are rarely taken up by the cells. Therefore the
laser-induced treatment causes damage mainly to the mem-
brane of the cell, which can be naturally repaired over time. This
temporary membrane permeability has been shown in cells
following shock treatments such as pulsed electromagnetic
ﬁelds and osmotic stress14 and suggests a similar phenomenon
following laser irradiation. On the other hand, the nonfunc-
tional particles (OEG-NPs) are internalized and they are mostly
found conﬁned within the endosomes, causing critical damage
not only at the cellular membrane but also at the subcellular
level leading to cell death.
The results of Figure 4 indicate a strong inﬂuence of the
presence and functionality of nanoparticles on the laser-in-
duced damage and recovery of HUVECs. To further assess the
inﬂuence of the treatment on cellular functions, we monitored
the expression levels of two speciﬁc marker genes following
exposure to laser irradiation. The marker genes selected here
are indicators of endothelial activation, encoding the endothe-
lial adhesion molecule 1 (ELAM-1) and the intercellular adhe-
sion molecule 1 (ICAM-1). These genes play a critical role in
angiogenesis and inﬂammation allowing the formation of new
blood vessels and the recruitment of endothelial progenitors
and inﬂammatory cells.15 A characteristic of these genes is that
their expression is sensitive to stress imposed by variations to the
cell surrounding environment (i.e., temperature changes).16 For
the gene expression experiments, cell cultures were treated for
10 min at a laser intensity of 12 or 24 W/cm2, followed by 1 h of
Figure 3. Phase contrast images of HUVECs before (a) and after (b, c) exposure toNIR laser (10min, 24W/cm2) and 1 h incubation at 37 C followed
by Trypan Blue viability staining (c). Rows represent HUVECs without particles (control) and KPQPRPLS-peptide functionalized hollow gold (pep-
OEG-HG), nanorods (pep-OEG-NR), and core-shell (pep-OEG-CS). Dashed circles represent laser spots. Scale bars represent 50 μm. Insets: detailed
parts of main ﬁgures showing local cell distribution and morphology.
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rest, and then stimulated for 5 h with TNF-R. Four diﬀerent spots
were exposed for each sample in order to achieve a large fraction of
treated cells in the gene expression experiment. More information
on the experimental protocols is available in the Supporting
Information.
The resultant gene proﬁles are shown in Figure 5. The graphs
indicate that in the presence of nanoparticles, both the ELAM-1
and ICAM-1 genes are signiﬁcantly (p < 0.05) down-regulated,
with a dependence on laser power. Overall, the hollow spheres
and nanorods show a stronger eﬀect on gene down-regulation in
comparison to the core-shell particles. Control experiments in
the absence of nanoparticles did not show any signiﬁcant change
in gene proﬁle, indicating an absence of stress response at these
laser intensities.
By comparing the gene expression and cell viability results, we
identify a number of remarkable trends. First, the gene expression
of the peptide-functionalized particles in Figure 5a at 12 W/cm2
is much smaller than that in the rest of the graphs. In particular
the comparison with OEG-type particles at the same laser
intensity is remarkable since both types of particles in panels a
and d of Figure 4 show a similar cell viability of around 35% at this
intensity. Thus, for the same survival rate, the eﬀect of laser
illumination on gene expression is much smaller for nanoparti-
cles attached to the cell membrane.
On the other hand, at 24W/cm2, a large gene down-regulation
is observed for both the peptide and OEG-type particles
(Figure 5b,d). Since gene expression proﬁling includes all cells
that survived the laser treatment, the data in Figure 5b include a
signiﬁcant number of cells from recovered cells (type II in
Figure 4), i.e., that have undergone a membrane rupture and
repair event. Clearly, from the gene expression proﬁles there is no
indication that these cells have reached a higher stress level than
the OEG-type of particles.
We point out that even at the lowest laser intensities of this
study, a sizable fraction of cells (25% for hollow-gold and
rods, 10% for core-shell) did not survive the laser treatment.
This suggests the presence of additional, nonthermal
mechanisms of cell damage,9 which will be addressed in
future studies. Such investigations may include eﬀects of
pulsed versus continuous illumination, and of local variations
in particle distribution in the cellular microenvironment and
subcellular compartmentalization.17
In conclusion, we have investigated a range of intensities in
which laser treatment of cells in the presence of plasmonic
nanoparticles is used to control the cellular response. Pro-
nounced diﬀerences are found between the laser-induced
eﬀects caused by OEG-type particles that are internalized into
the endosomes and by peptide-coated nanoparticles which
speciﬁcally target receptors present in the cellular membrane.
A window of laser intensities is found in which the peptide-
coated particles induce a recoverable rupture of the cellular
membrane. Our results indicate that the possible applications
of laser-induced plasmonic eﬀects on noncancerous cells
include the regulation of gene expression by application of
external stress and modulation of the permeability of cellular
membranes.
The use of HUVECs in our studies enables opportunities in
both imaging and therapeutics where the control of vascular
proliferation is a goal. Endothelial proliferation, especially in
tumors, can lead to increased risk of metastasis and a poorer
prognosis. Future research may be directed toward the control of
more complex cellular organization processes, such as angiogen-
esis, using plasmonically targeted laser treatment.
Figure 4. Cell viability for NP hyperthermia of HUVECs at various laser power densities, using hollow gold (HG) (a, d), rodlike (NR) (b, e), and core-
shell (CS) nanoparticles. Particles are attached to KPQPRPLS peptide (a-c) or coated with monocarboxy (1-mercaptoundec-11-yl) hexa(ethylene
glycol) (OEG) (d-f). Symbols indicate percentage of dead cells determined after 1 h (triangles) and 24 h (diamonds) of incubation, which followed
the exposure to the laser light. Numbered areas indicate (I) undamaged cells (green), (II) recovered cells after membrane rupture (blue), and
(III) damaged cells (red).
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